SCHEMBL18824232

SCHEMBL18824232

COC(=O)c1cc2cc(Cl)c(OC)cc2[nH]1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 4/20 0.48
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
XDH P47989 3/20 0.47
FGFR1 P11362 1/20 0.44
FGFR2 P21802 1/20 0.44
FGFR3 P22607 1/20 0.44
RXFP1 Q9HBX9 1/20 0.43
SRD5A1 P18405 1/20 0.43
SRD5A2 P31213 1/20 0.43
ALOX15 P16050 1/20 0.43
FLT3 P36888 2/20 0.42
PDGFRB P09619 1/20 0.42
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 2/20 0.42
GLA P06280 1/20 0.42
GAA P10253 1/20 0.42
NPC1 O15118 1/20 0.42
LMNA P02545 1/20 0.42
HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6514324 0.87 RXFP1 (0.53) POLBMEN1KMT2AXDHRXFP1
SCHEMBL30920789 0.86 KMT2A (0.46) POLBMEN1KMT2AFGFR1FGFR2
SCHEMBL27247640 0.86 KMT2A (0.46) POLBMEN1KMT2AFGFR1FGFR2
SCHEMBL19331953 0.86 SRD5A2 (0.56) POLBMEN1KMT2AFGFR1FGFR2
SCHEMBL18331904 0.86 ALOX15 (0.61) MEN1KMT2AFGFR1FGFR2FGFR3
SCHEMBL27247270 0.85 FGFR1 (0.46) POLBMEN1KMT2AFGFR1FGFR2
SCHEMBL30920628 0.85 FGFR1 (0.46) POLBMEN1KMT2AFGFR1FGFR2
SCHEMBL29217462 0.83 XDH (0.48) POLBMEN1KMT2AXDHRXFP1
SCHEMBL16030973 0.83 XDH (0.48) POLBMEN1KMT2AXDHRXFP1
SCHEMBL30988744 0.83 XDH (0.48) POLBMEN1KMT2AXDHRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180312493-A1 Antibiotic Compounds, Pharmaceutical Formulations Thereof And Methods And Uses Therefor CENTRE FOR DRUG RESEARCH AND DEVELOPMENT (CA) 2018-11-01 US disclosed
WO-2017075694-A1 ANTIBIOTIC COMPOUNDS, PHARMACEUTICAL FORMULATIONS THEREOF AND METHODS AND USES THEREFOR SIMON FRASER UNIVERSITY (CA) 2017-05-11 WO disclosed
WO-2017075694-A1 ANTIBIOTIC COMPOUNDS, PHARMACEUTICAL FORMULATIONS THEREOF AND METHODS AND USES THEREFOR SIMON FRASER UNIVERSITY (CA) 2017-05-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180312493-A1 Antibiotic Compounds, Pharmaceutical Formulations Thereof And Methods And Uses Therefor UGT1A8, CYP2C8, CXCL8 POLB 2549/4885MEN1 521/4885KMT2A 4107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.